查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1994357

功能性近红外线脑部造影市场：依产品类型、组件、波长范围及应用划分－2026年至2032年全球市场预测

Functional Near-infrared Optical Brain Imaging Market by Product Type, Components, Wavelength Range, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，功能性近红外线光学脑成像市场价值将达到 2.1915 亿美元，到 2026 年将成长至 2.3377 亿美元，到 2032 年将达到 3.722 亿美元，年复合成长率为 7.86%。

主要市场统计数据
基准年 2025 2.1915亿美元
预计年份：2026年 2.3377亿美元
预测年份 2032 3.722亿美元
复合年增长率 (%) 7.86%

这份基础文件简明扼要地说明了影响当前功能性近红外线脑部造影趋势的技术驱动因素、应用范围和生态系统动态。

功能性近红外线脑部造影（fNIRS）正从一项小众调查方法发展成为一个功能全面的平台，支援转化神经科学、临床工作流程和消费级脑机介面。本文概述了现代技术组件、核心应用领域以及不断发展的供应商、整合商和终端用户生态系统。该技术的非侵入性和相对较高的运动容错性使其应用范围从实验室扩展到临床环境、復健中心和应用研究领域。

设备架构、组件创新和演算法进步等方面的技术融合如何重塑产品权衡，并使其能够在现实世界环境中部署。

功能性近红外线光学脑成像领域正经历一场变革，其驱动力来自跨学科创新和不断变化终端用户的需求。连续波、频域和时域仪器的进步不仅提高了测量精度，也重新定义了设备的外形尺寸和工作环境。连续波系统变得更加节能紧凑，频域仪器透过相位分辨率测量提高了深度分辨率，而时域平台则不断突破光子飞行时间分辨率的极限。这些模式的创新相结合，在复杂性、便携性和生理分辨率之间形成了多种权衡，各机构必须认真考虑这些因素。

本检验了2025 年关税变化如何加速了整个成像生态系统的供应链韧性措施、模组化设计的采用以及区域製造调整。

美国于2025年实施的关税对功能性近红外线光学脑成像生态系统中相关人员的供应链和采购产生了切实的影响。关税带来的成本压力影响了进口组件，例如专用检测器、光纤和高精度光源，迫使采购团队重新评估其供应商组合和采购区域。因此，设备製造商加快了双重采购策略的实施，并加强了与供应商的合作，以降低对单一国家依赖的风险，并减少关税波动的影响。

将设备模式、组件架构和特定应用要求与策略性产品选择和检验优先顺序连结起来的详细细分观点。

市场区隔洞察揭示了影响产品开发、商业化选择和研究重点的微妙权衡。依产品类型，市场可分为三大类：连续波、频域、时域。这些模式的差异直接影响仪器的复杂性、校准要求和应用适用性。连续波方法因其紧凑性和成本效益，通常适用于消费级脑机介面和一些神经復健应用；而频域和时域系统则提供更高的深度分辨率和定量指标，这些指标与临床诊断和高级认知研究密切相关。

美洲、欧洲、中东和非洲以及亚太地区的区域管理体制、研究生态系统和製造能力在部署策略方面有何不同？

区域趋势为功能性近红外线光学脑成像领域的机构创造了独特的机会和营运考量。在美洲，强大的临床研究网络、活跃的私人投资环境以及完善的復健服务体系，为技术快速部署到临床试验和试点应用提供了支援。监管环境强调临床效用和安全性方面的证据，而报销因素也日益影响机构对成人和儿童诊断应用的优先排序。因此，将临床伙伴关係和以结果主导的检验纳入其商业化策略的公司，将更容易找到合适的部署途径。

参与企业如何平衡垂直整合、利基专业化和服务导向的商业化，以加速市场接受度并保持竞争优势？

功能性近红外线光学脑成像领域的企业级发展趋势表明，垂直整合和协同专业化都是关注的重点。成熟的医疗设备製造商通常透过将组件製造、系统整合和临床检验置于单一营运架构下来实现垂直整合，以确保品管、加快监管申报流程并保护智慧财产权。同时，敏捷的Start-Ups和专业供应商则专注于与大型合作伙伴授权或共同开发的创新技术，例如紧凑型检测器、先进光源和人工智慧驱动的讯号处理模组。

为市场领导建立具有韧性的供应链、加速临床检验以及创建互通性的、服务主导的商业化模式提供切实可行的策略步骤。

产业领导者必须采取切实可行的策略来应对技术复杂性、监管变化以及终端用户不断变化的需求。首先，应优先考虑模组化系统设计，以便快速更换检测器、光纤和光源，从而减少对单一供应商的依赖，并在组件变更时加快监管部门的重新检验。其次，应与医院和研究中心合作，将临床检验融入产品开发的早期阶段，产生可重复的结果数据，以消除支付者和临床医生的担忧。

透过整合与专家的初步访谈、技术评估和供应链分析，我们透过高度透明和多方面的调查方法得出经过检验的策略见解。

本执行摘要的调查方法透过整合多面向证据、跨领域专家访谈和严谨的技术评估，确保了分析的可靠性和实用性。主要资讯来源包括对学术研究人员、临床医生、采购负责人和医疗设备工程师的结构化访谈，旨在收集关于器材权衡、临床需求和推广障碍的不同观点。次要资讯来源包括同行评审文献、技术白皮书、监管指南和专利趋势，旨在检验技术进步并识别新兴创新丛集。

综合观点强调，技术选择、严格检验和营运弹性将决定未来几年主导临床和商业性应用的参与者。

总之，功能性近红外线光学脑部造影正处于转折点，技术成熟度、切实可行的商业化策略以及不断变化的监管预期相契合，预计将被临床医生和消费者更广泛地采用。仪器模式的选择——连续波、频域或时域——与组件架构和应用需求相互作用，共同塑造了独特的价值提案格局。同时，关税等政策变化凸显了健全的采购体系、模组化设计和区域製造柔软性的必要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 功能性近红外线光学脑部造影市场：依产品类型划分

  • 连续波
  • 频域
  • 时域

第九章 功能性近红外线光学脑造影市场：依组件划分

  • 检测器
    • 光电二极体
    • 光电倍增管
  • 光纤元件
    • 检测光纤
    • 光纤光源
  • 光源
    • 雷射
    • LED

第十章：波段范围分類的功能性近红外线脑部造影市场

  • 650～900 nm
  • 900～1,000 nm
  • 1000奈米或更大

第十一章 功能性近红外线脑部造影市场：按应用领域划分

  • 脑机介面
    • 辅助技术
    • 游戏与娱乐
  • 临床诊断
    • 成人诊断
    • 儿童诊断
  • 认知调查
    • 人机互动
    • 神经科学研究
  • 神经復健
    • 运动功能障碍復健
    • 中风復健

第十二章 功能性近红外线脑部造影市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 功能性近红外线脑部影像市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 功能性近红外线脑部影像市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国功能性近红外线脑部影像市场

第十六章：中国功能性近红外线光学脑部影像市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Artinis Medical Systems BV
  • BIOPAC Systems, Inc.
  • Gowerlabs Ltd
  • Hamamatsu Photonics KK
  • Hitachi, Ltd
  • ISS, Inc.
  • Kernel Flow Inc.
  • NIRx Medizintechnik GmbH
  • Shimadzu Corporation
  • TechEn, Inc.
Product Code: MRR-1A1A064C05BB

The Functional Near-infrared Optical Brain Imaging Market was valued at USD 219.15 million in 2025 and is projected to grow to USD 233.77 million in 2026, with a CAGR of 7.86%, reaching USD 372.20 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 219.15 million
Estimated Year [2026] USD 233.77 million
Forecast Year [2032] USD 372.20 million
CAGR (%) 7.86%

A concise foundation describing technological enablers, application breadth, and ecosystem dynamics shaping the current trajectory of functional near-infrared optical brain imaging

Functional near-infrared optical brain imaging (fNIRS) is maturing from a niche research modality into a versatile platform that supports translational neuroscience, clinical workflows, and consumer-oriented brain computer interfaces. This introduction outlines the contemporary technological building blocks, core application areas, and the evolving ecosystem of suppliers, integrators, and end users. The modality's noninvasive nature and relative tolerance to motion have expanded attention beyond laboratory settings and into clinics, rehabilitation centers, and applied research contexts.

Technological advances in light sources, photodetectors, and signal processing algorithms have improved temporal stability and depth sensitivity, enabling more robust interpretation of hemodynamic signals. At the same time, the convergence of miniaturized hardware, cloud-native analytics, and multimodal data fusion has created new possibilities for continuous monitoring and closed-loop interventions. Regulatory maturation and a growing emphasis on reproducibility in neuroscience contribute to broader institutional adoption, while interest from adjacent markets such as assistive technologies and gaming fuels private-sector innovation.

This introduction frames the remainder of the executive summary by emphasizing how technological capabilities, application demand, and an expanding supply chain interplay to shape near-term strategic choices. It prepares the reader to examine transformative shifts, tariff impacts, segmentation nuances, regional differentiators, and company-level strategies that collectively inform actionable priorities for leaders in this rapidly evolving field.

How technological convergence across instrument architectures, component innovation, and algorithmic advances is reshaping product tradeoffs and enabling real-world deployments

The landscape for functional near-infrared optical brain imaging is undergoing transformative shifts driven by cross-disciplinary innovation and changing end-user expectations. Advances in continuous wave, frequency domain, and time domain instrumentation are not only improving measurement fidelity but are also redefining device form factors and use environments. Continuous wave systems have become more energy efficient and compact, frequency domain instruments have improved depth discrimination via phase-resolved measurements, and time domain platforms continue to push the envelope in terms of photon time-of-flight resolution. Together, these modality innovations create a spectrum of tradeoffs between complexity, portability, and physiological resolution that organizations must navigate.

Moreover, improvements in component-level technologies such as detectors, fiber optics, and light sources are enabling smaller, more integrated systems with lower power consumption. Photodiodes and advanced solid-state photomultipliers are enhancing sensitivity, while laser and LED source innovations are expanding wavelength stability and safety margins. Concurrently, machine learning-based signal processing and artifact rejection techniques are increasing the reliability of hemodynamic interpretations across diverse populations and motion conditions. These algorithmic advances facilitate real-world deployments, from clinic to community settings, by reducing the need for controlled laboratory conditions.

Finally, commercial dynamics are shifting as partnerships between device manufacturers, software providers, and clinical institutions deepen. This institutionalization fosters standardized protocols, interoperability expectations, and clearer pathways for validation and reimbursement. As a result, the field is moving from pilot-driven curiosity toward scalable clinical and consumer applications, and organizations that align product development with interoperable standards and validated clinical workflows will capture disproportionate strategic advantage.

Examining how 2025 tariff shifts accelerated supply chain resilience measures, modular design adoption, and regional manufacturing adjustments across the imaging ecosystem

The imposition of United States tariffs in 2025 created tangible supply chain and procurement implications for participants in the functional near-infrared optical brain imaging ecosystem. Tariff-driven cost pressures affected imported components such as specialized detectors, optical fibers, and precision light sources, prompting procurement teams to reassess vendor portfolios and sourcing geographies. In turn, device manufacturers accelerated dual-sourcing strategies and closer supplier integration to mitigate the risk of single-country dependence and reduce exposure to tariff volatility.

As a consequence, organizations increasingly emphasized design for supply chain resilience, adopting modular architectures that permit component substitution without extensive redesign. This transition to modularity enhanced flexibility when qualifying alternative suppliers and reduced time-to-re-certification for functional subsystems. Additionally, procurement teams scrutinized total landed cost and lifecycle maintenance implications, shifting some purchasing priorities from lowest-cost bids toward partners with proven quality control, regulatory traceability, and logistics reliability.

Moreover, the tariffs catalyzed regional manufacturing decisions and localized assembly strategies. Some stakeholders expanded manufacturing or final-assembly operations in regions less impacted by tariff constraints to preserve price competitiveness for end customers. At the same time, tariff-related uncertainty reinforced the importance of long-term supplier contracts and strategic inventory management, with organizations balancing the costs of safety stock against the operational complexity of larger warehouses. Ultimately, the tariff environment of 2025 highlighted that policy shocks can accelerate structural shifts in sourcing strategies and design philosophies across the sector.

In-depth segmentation perspective connecting instrument modalities, component architectures, and application-specific requirements to strategic product choices and validation priorities

Segmentation insights reveal the nuanced tradeoffs that shape product development, commercialization choices, and research priorities. Based on Product Type, the market is studied across Continuous Wave, Frequency Domain, and Time Domain, and this modality differentiation directly influences instrument complexity, calibration requirements, and application suitability. Continuous Wave approaches typically favor compactness and cost-efficiency, making them attractive for consumer-facing brain computer interfaces and some neurorehabilitation contexts, whereas Frequency Domain and Time Domain systems provide enhanced depth resolution and quantitative metrics that align closely with clinical diagnostics and advanced cognitive research.

Based on Components, the market is studied across Detector, Fiber Optic Components, and Light Source. The Detector is further studied across Photodiode and Photomultiplier Tube, with photodiodes offering robustness and low power consumption that support wearable applications and photomultiplier tubes delivering superior sensitivity for high-resolution laboratory or clinical diagnostics. The Fiber Optic Components is further studied across Detector Fibers and Source Fibers, and fiber selection impacts signal throughput, probe ergonomics, and sterilization protocols in clinical settings. The Light Source is further studied across Laser and Led, and the choice between laser and LED sources affects wavelength precision, safety classification, and cost structure.

Based on Application, the market is studied across Brain Computer Interfaces, Clinical Diagnostics, Cognitive Research, and Neurorehabilitation. The Brain Computer Interfaces is further studied across Assistive Technologies and Gaming & Entertainment, each with distinct user experience and regulatory considerations. The Clinical Diagnostics is further studied across Adult Diagnostics and Pediatric Diagnostics, reflecting divergent physiological baselines and clinical workflow requirements. The Cognitive Research is further studied across Human Computer Interaction and Neuroscience Research, both driving different data quality and temporal resolution needs. The Neurorehabilitation is further studied across Motor Disorder Rehabilitation and Stroke Rehabilitation, applications that impose specific requirements for portability, real-time feedback, and integration with therapeutic regimens. These layered segmentation lenses clarify where design tradeoffs and commercialization strategies must align to deliver credible value propositions.

How regional regulatory regimes, research ecosystems, and manufacturing capabilities create distinct strategies for deployment across Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics create differentiated opportunity spaces and operational considerations for organizations in functional near-infrared optical brain imaging. In the Americas, strong clinical research networks, an active private investment landscape, and well-established rehabilitation services support rapid technology translation into clinical trials and pilot deployments. The regulatory environment emphasizes evidence of clinical utility and safety, and reimbursement considerations increasingly shape how organizations prioritize adult and pediatric diagnostic applications. Consequently, companies that integrate clinical partnerships and outcomes-driven validation into their commercialization strategies will find more receptive adoption pathways.

In Europe, Middle East & Africa, the ecosystem is characterized by diverse regulatory regimes and a pronounced emphasis on harmonization and standards. Pan-European research consortia and centralized funding mechanisms enable multicenter validation studies that amplify scientific credibility. At the same time, Middle Eastern and African markets present uneven infrastructure and adoption curves, encouraging tailored deployment strategies and partnerships with regional healthcare providers. These geographic nuances mean that product modularity, multilingual software support, and flexible deployment options are critical for sustained success across the region.

In Asia-Pacific, rapid adoption of digital health technologies, growing manufacturing capabilities, and a dynamic research community create a fertile environment for both high-volume device production and large-scale trials. Investment in local supply chains and component sourcing is common, and regional regulatory pathways are evolving to accommodate digital and AI-enabled diagnostics. As a result, organizations that align manufacturing strategy with regional compliance, local clinical validation, and culturally relevant user experience design will be better positioned to capture long-term engagement across diverse Asia-Pacific markets.

How market participants balance vertical integration, niche specialization, and service-oriented commercialization to drive adoption and sustain competitive advantage

Company-level dynamics in the functional near-infrared optical brain imaging sector demonstrate a dual emphasis on vertical integration and collaborative specialization. Established medical device firms often pursue vertical integration by bringing component manufacturing, system integration, and clinical validation under the same operational umbrella to control quality, accelerate regulatory submissions, and protect intellectual property. At the same time, nimble startups and specialized suppliers focus on discrete innovations-such as compact detectors, advanced light sources, or AI-driven signal processing modules-that can be licensed or co-developed with larger partners.

Licensing models and strategic partnerships remain central to scaling complex products that require clinical acceptance and software maturity. Many companies adopt hybrid commercialization strategies that combine direct sales for clinical customers with channel partnerships for research institutions and consumer markets. Furthermore, service-based revenue models-such as cloud analytics subscriptions, device-as-a-service offerings, and managed clinical trials-are emerging as ways to stabilize recurring income and deepen customer engagement. These models also create opportunities for lifecycle upgrades and data-driven validation that reinforce long-term value propositions.

Finally, corporate strategies increasingly prioritize evidence generation and interoperability. Firms that invest in robust clinical validation, conform to emerging data standards, and provide APIs for integration with electronic health records and third-party analytics platforms build stronger cases for adoption. In short, company success will depend on the ability to combine technical differentiation with pragmatic partnerships and sustainable commercialization models.

Practical strategic steps for market leaders to build resilient supply chains, accelerate clinical validation, and create interoperable, service-led commercialization models

Industry leaders must adopt pragmatic, actionable strategies to navigate technological complexity, regulatory variability, and evolving end-user expectations. First, prioritize modular system design that enables rapid substitution of detectors, fibers, and light sources to reduce dependency on single-source suppliers and to accelerate regulatory revalidation when components change. Second, embed clinical validation into early product development by partnering with hospitals and research centers to generate reproducible outcomes data that answers payer and clinician concerns.

Third, invest in algorithmic robustness and explainable models to ensure that signal processing advances translate into clinically interpretable endpoints. Robust analytics reduce user training burdens and support regulatory submissions, while explainability increases clinician trust. Fourth, pursue selective regional manufacturing or final assembly strategies to mitigate tariff exposure and shorten supply chain lead times. Localization should be balanced with global quality control to maintain device consistency across markets.

Fifth, cultivate interoperable software ecosystems through open APIs and standardized data formats to facilitate integration with electronic health records and third-party analytics. This interoperability drives adoption by reducing workflow friction. Finally, adopt flexible commercial models that combine capital sales with subscription-based analytics and service contracts to create recurring revenue and sustained customer engagement. Together, these recommendations provide a clear operational roadmap for leaders seeking to translate research momentum into durable market presence.

A transparent and triangulated methodology that blends primary expert interviews, technical assessments, and supply chain analysis to produce validated strategic insights

The research methodology underpinning this executive summary combined multi-source evidence synthesis, cross-functional expert interviews, and rigorous technical assessment to ensure analytical credibility and practical relevance. Primary inputs included structured interviews with academic investigators, clinical practitioners, procurement specialists, and device engineers to capture diverse perspectives on instrumentation tradeoffs, clinical needs, and implementation barriers. Secondary inputs encompassed peer-reviewed literature, technical white papers, regulatory guidance, and patent landscapes to validate technological trajectories and identify emergent innovation clusters.

Analytical techniques integrated component-level technical review with application-specific use case mapping to align product attributes with end-user requirements. Comparative assessments examined continuous wave, frequency domain, and time domain approaches alongside detector, fiber optic, and light source options to evaluate their suitability across clinical diagnostics, cognitive research, brain computer interfaces, and neurorehabilitation. Supply chain analysis incorporated tariff impacts, supplier concentration metrics, and manufacturing capabilities to assess vulnerability and resilience.

Finally, findings were iteratively validated through expert workshops that stress-tested assumptions and refined recommendations for decision-makers. This triangulated approach ensured that conclusions rest on convergent evidence rather than single-source assertions, delivering a robust foundation for strategic planning and operational execution.

A consolidated perspective emphasizing how technical choices, validation rigor, and operational agility will determine who leads clinical and commercial adoption in the coming years

In conclusion, functional near-infrared optical brain imaging stands at an inflection point where technical maturation, pragmatic commercialization strategies, and evolving regulatory expectations align to enable broader clinical and consumer adoption. Instrument modality choices-across continuous wave, frequency domain, and time domain-interact with component architectures and application requirements to create a landscape of distinct value propositions. Simultaneously, policy shifts such as tariffs have underscored the need for resilient sourcing, modular designs, and regional manufacturing flexibility.

As a result, organizations that combine rigorous clinical validation, interoperable software strategies, and flexible commercial models will be best positioned to capture long-term value. Collaboration between device manufacturers, software innovators, clinical institutions, and payers will accelerate meaningful outcomes and patient-centered applications. Ultimately, the future trajectory of this field will be determined less by a single technological breakthrough and more by the ability of stakeholders to operationalize evidence, standardize workflows, and sustainably deliver demonstrable clinical and user benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Functional Near-infrared Optical Brain Imaging Market, by Product Type

  • 8.1. Continuous Wave
  • 8.2. Frequency Domain
  • 8.3. Time Domain

9. Functional Near-infrared Optical Brain Imaging Market, by Components

  • 9.1. Detector
    • 9.1.1. Photodiode
    • 9.1.2. Photomultiplier Tube
  • 9.2. Fiber Optic Components
    • 9.2.1. Detector Fibers
    • 9.2.2. Source Fibers
  • 9.3. Light Source
    • 9.3.1. Laser
    • 9.3.2. Led

10. Functional Near-infrared Optical Brain Imaging Market, by Wavelength Range

  • 10.1. 650-900 nm
  • 10.2. 900-1,000 nm
  • 10.3. Above 1,000 nm

11. Functional Near-infrared Optical Brain Imaging Market, by Application

  • 11.1. Brain Computer Interfaces
    • 11.1.1. Assistive Technologies
    • 11.1.2. Gaming & Entertainment
  • 11.2. Clinical Diagnostics
    • 11.2.1. Adult Diagnostics
    • 11.2.2. Pediatric Diagnostics
  • 11.3. Cognitive Research
    • 11.3.1. Human Computer Interaction
    • 11.3.2. Neuroscience Research
  • 11.4. Neurorehabilitation
    • 11.4.1. Motor Disorder Rehabilitation
    • 11.4.2. Stroke Rehabilitation

12. Functional Near-infrared Optical Brain Imaging Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Functional Near-infrared Optical Brain Imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Functional Near-infrared Optical Brain Imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Functional Near-infrared Optical Brain Imaging Market

16. China Functional Near-infrared Optical Brain Imaging Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Artinis Medical Systems B.V.
  • 17.6. BIOPAC Systems, Inc.
  • 17.7. Gowerlabs Ltd
  • 17.8. Hamamatsu Photonics K.K.
  • 17.9. Hitachi, Ltd
  • 17.10. ISS, Inc.
  • 17.11. Kernel Flow Inc.
  • 17.12. NIRx Medizintechnik GmbH
  • 17.13. Shimadzu Corporation
  • 17.14. TechEn, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FREQUENCY DOMAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FREQUENCY DOMAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FREQUENCY DOMAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY TIME DOMAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY TIME DOMAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY TIME DOMAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTODIODE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTODIODE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTODIODE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTOMULTIPLIER TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTOMULTIPLIER TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PHOTOMULTIPLIER TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SOURCE FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SOURCE FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SOURCE FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 650-900 NM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 650-900 NM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 650-900 NM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 900-1,000 NM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 900-1,000 NM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY 900-1,000 NM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ABOVE 1,000 NM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ABOVE 1,000 NM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ABOVE 1,000 NM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ASSISTIVE TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ASSISTIVE TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ASSISTIVE TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GAMING & ENTERTAINMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GAMING & ENTERTAINMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GAMING & ENTERTAINMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ADULT DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ADULT DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY ADULT DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PEDIATRIC DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PEDIATRIC DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PEDIATRIC DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY HUMAN COMPUTER INTERACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY HUMAN COMPUTER INTERACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY HUMAN COMPUTER INTERACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROSCIENCE RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROSCIENCE RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROSCIENCE RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY MOTOR DISORDER REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY MOTOR DISORDER REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY MOTOR DISORDER REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY STROKE REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY STROKE REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 207. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 208. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 213. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 214. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 215. GCC FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 244. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY WAVELENGTH RANGE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY BRAIN COMPUTER INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COGNITIVE RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 251. G7 FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY NEUROREHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY DETECTOR, 2018-2032 (USD MILLION)
  • TABLE 256. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY FIBER OPTIC COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO FUNCTIONAL NEAR-INFRARED OPTICAL BRAIN IMAGING MARKET SIZE, BY LIGHT SOURCE, 2018-203